Literature DB >> 33537521

Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.

Nadine Attal1, Valéria Martinez1,2,3, Didier Bouhassira1,2.   

Abstract

Although coronavirus disease 2019 (COVID-19) most commonly manifests with acute respiratory symptoms, one very common symptom of COVID-19 is pain. As COVID-19 often causes peripheral or central neurological complications, it is anticipated that a number of the chronic pain complications of COVID-19 will be neuropathic. This review first examines the most common viral infections responsible for neurological complications including neuropathic pain. These encompass herpes zoster, HIV, poliovirus, enteroviruses, and several tropical viruses. Neurological complications of COVID-19 including in particular Guillain-Barré syndrome, myelitis, and stroke are reviewed with regards to their potential risk of chronic neuropathic pain. Prospective longitudinal cohorts of patients should be implemented to evaluate the exact risk of neuropathic pain after COVID-19.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain.

Entities:  

Keywords:  COVID-19; Narrative review; Neurological complications; Neuropathic pain; SARS-CoV-2

Year:  2021        PMID: 33537521      PMCID: PMC7850724          DOI: 10.1097/PR9.0000000000000884

Source DB:  PubMed          Journal:  Pain Rep        ISSN: 2471-2531


  65 in total

1.  Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.

Authors:  Henrik Gonzalez; Katharina Stibrant Sunnerhagen; Inger Sjöberg; Georgios Kaponides; Tomas Olsson; Kristian Borg
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

2.  The lasting misery of coronavirus long-haulers.

Authors:  Michael Marshall
Journal:  Nature       Date:  2020-09       Impact factor: 49.962

3.  Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.

Authors:  X Moisset; D Bouhassira; J Avez Couturier; H Alchaar; S Conradi; M H Delmotte; M Lanteri-Minet; J P Lefaucheur; G Mick; V Piano; G Pickering; E Piquet; C Regis; E Salvat; N Attal
Journal:  Rev Neurol (Paris)       Date:  2020-04-07       Impact factor: 2.607

Review 4.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

5.  Survivorship after COVID-19 ICU stay.

Authors:  Megan M Hosey; Dale M Needham
Journal:  Nat Rev Dis Primers       Date:  2020-07-15       Impact factor: 52.329

6.  Myeloradiculopathy associated with chikungunya virus infection.

Authors:  Anna M Bank; Ayush Batra; Rene A Colorado; Jennifer L Lyons
Journal:  J Neurovirol       Date:  2015-08-26       Impact factor: 3.739

Review 7.  A systematic review and meta-analysis of risk factors for postherpetic neuralgia.

Authors:  Harriet J Forbes; Sara L Thomas; Liam Smeeth; Tim Clayton; Ruth Farmer; Krishnan Bhaskaran; Sinéad M Langan
Journal:  Pain       Date:  2016-01       Impact factor: 7.926

8.  Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study.

Authors:  Tudor J C Phillips; Matthew Brown; Juan D Ramirez; James Perkins; Yohannes W Woldeamanuel; Amanda C de C Williams; Christine Orengo; David L H Bennett; Istvan Bodi; Sarah Cox; Christoph Maier; Elena K Krumova; Andrew S C Rice
Journal:  Pain       Date:  2014-06-26       Impact factor: 6.961

9.  Acute transverse myelitis in COVID-19 infection.

Authors:  Chian Chiang Nicholas Chow; John Magnussen; Jerome Ip; Yuen Su
Journal:  BMJ Case Rep       Date:  2020-08-11

10.  Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study.

Authors:  Maria Lúcia Brito Ferreira; Maria de Fatima Pessoa Militão de Albuquerque; Carlos Alexandre Antunes de Brito; Rafael Freitas de Oliveira França; Álvaro José Porto Moreira; Maria Íris de Morais Machado; Roberta da Paz Melo; Raquel Medialdea-Carrera; Solange Dornelas Mesquita; Marcela Lopes Santos; Ravi Mehta; Rafael Ramos E Silva; Sonja E Leonhard; Mark Ellul; Anna Rosala-Hallas; Girvan Burnside; Lance Turtle; Michael J Griffiths; Bart C Jacobs; Maneesh Bhojak; Hugh J Willison; Lindomar José Pena; Carlos A Pardo; Ricardo A A Ximenes; Celina Maria Turchi Martelli; David W G Brown; Marli Tenório Cordeiro; Suzannah Lant; Tom Solomon
Journal:  Lancet Neurol       Date:  2020-09-16       Impact factor: 59.935

View more
  17 in total

Review 1.  The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection.

Authors:  Brian Walitt; Tory P Johnson
Journal:  Curr Opin Neurol       Date:  2022-06-01       Impact factor: 6.283

2.  Transition of COVID-19 to endemic phase and emergence of COVID-19 related neuropathic pain.

Authors:  Jeong Il Choi
Journal:  Korean J Pain       Date:  2022-07-01

3.  A year like no other: introduction to a special issue on COVID-19 and pain.

Authors:  Michael C Rowbotham; Lars Arendt-Nielsen
Journal:  Pain Rep       Date:  2021-05-10

Review 4.  Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components.

Authors:  Miao-Miao Tian; Yu-Xiang Li; Shan Liu; Chun-Hao Zhu; Xiao-Bing Lan; Juan Du; Lin Ma; Jia-Mei Yang; Ping Zheng; Jian-Qiang Yu; Ning Liu
Journal:  Molecules       Date:  2021-12-31       Impact factor: 4.411

5.  Effects of COVID-19 Social Distancing Measures in Individuals with Chronic Pain Living in Spain in the Late Stages of the Lockdown.

Authors:  Jordi Miró; Elisabet Sánchez-Rodríguez; Alexandra Ferreira-Valente; José Pais-Ribeiro; Antonella Ciaramella
Journal:  Int J Environ Res Public Health       Date:  2021-11-09       Impact factor: 3.390

6.  The Post-COVID 19 long term surveillance study sequel to an add-on Ayurveda regimen.

Authors:  Pankaj Wanjarkhedkar; Girish Sarade; Bharat Purandare; Dhananjay Kelkar
Journal:  J Ayurveda Integr Med       Date:  2022-04-06

Review 7.  Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.

Authors:  Paul A Boakye; Shao-Jun Tang; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-25

Review 8.  Neuropathic Pain in Neurologic Disorders: A Narrative Review.

Authors:  Dimos-Dimitrios Mitsikostas; Eleni Moka; Enrique Orrillo; Caterina Aurilio; Athina Vadalouca; Antonella Paladini; Giustino Varrassi
Journal:  Cureus       Date:  2022-02-20

9. 

Authors:  Alan Juárez-Belaúnde; Andres Ancor Serrano Afonso
Journal:  Rev Esp Anestesiol Reanim (Engl Ed)       Date:  2021-09-24

10.  Neuropathic pain post-COVID-19: a case report.

Authors:  Matthew McWilliam; Michael Samuel; Fadi Hasan Alkufri
Journal:  BMJ Case Rep       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.